The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcnab James R since 2005.
The trader's CIK number is 1190126.
At the time of the last reporting, Mcnab James R was the Director of Titan Pharmaceuticals Inc. (stock ticker symbol TTNP).
Also see all insider trading activities at Titan Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CRIS | 0 | $0 | 560,322 | $1,387,860 | 0 | $0 |
| 2013 | CRIS | 50,000 | $200,000 | 50,000 | $200,000 | 0 | $0 |
| 2012 | CRIS | 0 | $0 | 300,000 | $1,426,170 | 257,500 | $587,872 |
| 2011 | CRIS | 0 | $0 | 75,000 | $245,250 | 397,500 | $561,270 |
| 2008 | CRIS | 150,000 | $227,300 | 0 | $0 | 0 | $0 |
| 2005 | CRIS | 0 | $0 | 100,522 | $403,814 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | TTNP | 200,000 | $50,000 | 0 | $0 | 0 | $0 |
| 2016 | TTNP | 36,363 | $192,307 | 0 | $0 | 0 | $0 |
2. Titan Pharmaceuticals Inc (TTNP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-03 | CRIS | Sale | 30,000 | 2.19 | 65,550 |
| 2017-05-04 | CRIS | Sale | 30,100 | 1.97 | 59,146 |
| 2017-05-05 | CRIS | Sale | 16,176 | 1.90 | 30,718 |
| 2017-04-28 | CRIS | Sale | 42,949 | 2.44 | 105,010 |
| 2017-05-01 | CRIS | Sale | 38,113 | 2.38 | 90,708 |
| 2017-05-02 | CRIS | Sale | 35,646 | 2.31 | 82,306 |
| 2017-04-25 | CRIS | Sale | 56,940 | 2.60 | 148,328 |
| 2017-04-27 | CRIS | Sale | 37,202 | 2.57 | 95,609 |
| 2017-04-26 | CRIS | Sale | 52,552 | 2.65 | 139,105 |
| 2017-04-20 | CRIS | Sale | 22,541 | 2.66 | 59,981 |
| 2017-04-21 | CRIS | Sale | 45,705 | 2.58 | 117,827 |
| 2017-04-24 | CRIS | Sale | 42,076 | 2.56 | 107,882 |
| 2017-04-20 | CRIS | Sale | 22,541 | 2.66 | 59,981 |
| 2017-04-21 | CRIS | Sale | 45,705 | 2.58 | 117,827 |
| 2017-04-24 | CRIS | Sale | 42,076 | 2.56 | 107,882 |
| 2013-08-16 | CRIS | Buy | 50,000 | 4.00 | 200,000 |
| 2013-08-16 | CRIS | Sale | 50,000 | 4.00 | 200,000 |
| 2012-06-18 | CRIS | Sale | 150,000 | 4.75 | 712,500 |
| 2012-06-19 | CRIS | Sale | 139,000 | 4.76 | 661,640 |
| 2012-06-15 | CRIS | Sale | 11,000 | 4.73 | 52,030 |
| 2012-01-30 | CRIS | Option Ex | 257,500 | 2.28 | 587,872 |
| 2011-03-31 | CRIS | Sale | 25,000 | 3.25 | 81,250 |
| 2011-03-30 | CRIS | Sale | 25,000 | 3.28 | 82,000 |
| 2011-03-29 | CRIS | Sale | 25,000 | 3.28 | 82,000 |
| 2011-03-18 | CRIS | Option Ex | 397,500 | 1.41 | 561,270 |
| 2008-08-06 | CRIS | Buy | 50,000 | 1.56 | 78,150 |
| 2008-08-06 | CRIS | Buy | 50,000 | 1.56 | 78,150 |
| 2008-06-06 | CRIS | Buy | 50,000 | 1.42 | 71,000 |
| 2005-05-19 | CRIS | Sale | 522 | 4.05 | 2,114 |
| 2005-05-18 | CRIS | Sale | 100,000 | 4.02 | 401,700 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-09-21 | TTNP | Buy | 200,000 | .25 | 50,000 |
| 2016-05-31 | TTNP | Buy | 20,000 | 7.03 | 140,600 |
| 2016-01-13 | TTNP | Buy | 16,363 | 3.16 | 51,707 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcnab James R (Director of Titan Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.